Whipple Triad – Diagnostic Criteria for Hypoglycemia

What is the Whipple Triad?

The Whipple Triad is a clinical diagnostic criterion used to confirm hypoglycemia (low blood sugar). It is named after the American surgeon Allen Oldfather Whipple, who first described these three conditions. All three criteria must be present simultaneously to establish a clinically significant hypoglycemic episode.

The Three Criteria of the Whipple Triad

• 1. Symptoms of hypoglycemia: The patient presents with typical signs of low blood sugar, such as trembling, sweating, palpitations, confusion, dizziness, or impaired consciousness.
• 2. Low blood glucose level: A low plasma glucose value is measured at the time of symptoms – generally below 2.8 mmol/L (50 mg/dL) in adults.
• 3. Relief of symptoms after glucose administration: The symptoms resolve or significantly improve after glucose (dextrose) is given.

Clinical Significance

The Whipple Triad is a fundamental diagnostic tool in endocrinology and internal medicine. It helps differentiate true hypoglycemia from other conditions that may cause similar symptoms, such as panic attacks, cardiac arrhythmias, or neurological disorders.

The Whipple Triad is particularly important in the evaluation of:

• Insulinoma – an insulin-secreting tumor of the pancreas
• Hypoglycemia in diabetes mellitus (especially under insulin therapy or sulfonylurea treatment)
• Reactive hypoglycemia occurring after meals
• Fasting hypoglycemia of unknown origin

Causes of Hypoglycemia

Possible causes in which the Whipple Triad may be fulfilled include:

• Overdose of insulin or blood glucose-lowering medications
• Insulinoma (benign or malignant tumor of the pancreas)
• Severe liver or kidney disease
• Hormonal deficiencies (e.g., cortisol or growth hormone deficiency)
• Prolonged fasting or malnutrition
• Critical illness (e.g., sepsis)

Diagnosis and Workup

When the Whipple Triad is identified, further diagnostic steps are required to determine the underlying cause. These include:

• Measurement of insulin, C-peptide, and proinsulin in the blood during the hypoglycemic episode
• A 72-hour fasting test to provoke hypoglycemia under controlled conditions
• Imaging studies (ultrasound, CT, MRI) to rule out an insulinoma

Treatment

Treatment depends on the underlying cause. Acute hypoglycemia is corrected by oral or intravenous glucose administration. Long-term management is guided by the diagnosis – insulinoma typically requires surgical removal, while medication-induced hypoglycemia calls for a review and adjustment of the treatment regimen.

References

1. Cryer PE, Axelrod L, Grossman AB et al. – Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 2009; 94(3): 709–728.
2. Kasper DL, Fauci AS, Hauser SL et al. – Harrison's Principles of Internal Medicine, 20th Edition. McGraw-Hill Education, 2018.
3. Service FJ – Hypoglycemic Disorders. New England Journal of Medicine, 1995; 332(17): 1144–1152.